Tarsus Pharmaceuticals, Inc.
TARSNASDAQHealthcare● Active
$60.82
+$1.18(+1.98%)
Market Cap$2.6B
P/E Ratio—
52W High$85.25
52W Low$38.51
Tarsus Pharmaceuticals, Inc. (TARS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TARS · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.42B | $0.29B | $0.23B | $0.22B | $0.17B |
| Net Receivables | $0.09B | $0.05B | $0.02B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.52B | $0.36B | $0.26B | $0.23B | $0.18B |
| PP&E Net | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.56B | $0.38B | $0.27B | $0.23B | $0.18B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.02B | $0.03B | $0.02B | $0.01B | $0.00B |
| Total Current Liabilities | $0.14B | $0.08B | $0.04B | $0.02B | $0.01B |
| Long-Term Debt | $0.08B | $0.07B | $0.03B | $0.02B | $0.00B |
| Total Liabilities | $0.22B | $0.15B | $0.07B | $0.03B | $0.01B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.43B) | ($0.36B) | ($0.24B) | ($0.11B) | ($0.05B) |
| Total Stockholders Equity | $0.34B | $0.22B | $0.20B | $0.19B | $0.17B |
| Total Liab & Equity(computed) | $0.56B | $0.38B | $0.27B | $0.23B | $0.18B |
| Debt Summary | |||||
| Total Debt | $0.09B | $0.07B | $0.03B | $0.02B | $0.00B |
| Net Debt | ($0.09B) | ($0.02B) | ($0.19B) | ($0.05B) | ($0.17B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Tarsus Pharmaceuticals, Inc. data
About Tarsus Pharmaceuticals, Inc. (TARS) Balance Sheet
Tarsus Pharmaceuticals, Inc. (TARS) balance sheet shows total assets of $0.56B with cash of $0.42B. Total liabilities are $0.22B, total debt $0.09B, and stockholders equity $0.34B.
Frequently asked questions
TARS · 4 questionsTarsus Pharmaceuticals, Inc. has total debt of $0.09B with net debt of ($0.09B).
TARS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10